<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>HPC药闻药事 | wechat-feeds</title><link>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</link><description>传递医药资讯 分享法规知识</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 07 Apr 2021 10:13:43 +0800</pubDate><image><url>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</url><title>HPC药闻药事 | wechat-feeds</title><link>http://MzA3NTQyMTk5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>关注杜丨十年来首款，又一多动症治疗新药获FDA批准</title><link>https://mp.weixin.qq.com/s/uiC5Odx8-aIRQHBrAfZrlg</link><description></description><content:encoded><![CDATA[关注杜丨十年来首款，又一多动症治疗新药获FDA批准]]></content:encoded><pubDate>Wed, 07 Apr 2021 10:06:54 +0800</pubDate></item><item><title>关注杜丨又一膀胱功能障碍药物，Myrbetriq获FDA批准</title><link>https://mp.weixin.qq.com/s/CoRcKHYot-FYt2m5AD3UwA</link><description></description><content:encoded><![CDATA[关注杜丨又一膀胱功能障碍药物，Myrbetriq获FDA批准]]></content:encoded><pubDate>Mon, 29 Mar 2021 13:59:59 +0800</pubDate></item><item><title>招聘国际药品注册人员</title><link>https://mp.weixin.qq.com/s/UENV7i46HgZnxl3YNEJiJQ</link><description></description><content:encoded><![CDATA[招聘国际药品注册人员]]></content:encoded><pubDate>Fri, 19 Mar 2021 22:07:49 +0800</pubDate></item><item><title>关注杜丨FDA批准首个抗癌肽偶联药物Pepaxto，治疗多发性骨髓瘤</title><link>https://mp.weixin.qq.com/s/mbl7pveWT9xOnzYA7-7WzQ</link><description></description><content:encoded><![CDATA[关注杜丨FDA批准首个抗癌肽偶联药物Pepaxto，治疗多发性骨髓瘤]]></content:encoded><pubDate>Wed, 03 Mar 2021 09:17:19 +0800</pubDate></item><item><title>关注杜丨FDA批准靶向药物Amondys 45：首个外显子45跳跃型DMD疗法</title><link>https://mp.weixin.qq.com/s/cnY7uvKv2z10lMP6SwtfEQ</link><description></description><content:encoded><![CDATA[关注杜丨FDA批准靶向药物Amondys 45：首个外显子45跳跃型DMD疗法]]></content:encoded><pubDate>Mon, 01 Mar 2021 09:32:41 +0800</pubDate></item><item><title>关注杜丨单药疗法PD-1抑制剂获FDA批准，治疗晚期NSCLC</title><link>https://mp.weixin.qq.com/s/BozRBspEfrQPnsOcpXeHLA</link><description></description><content:encoded><![CDATA[关注杜丨单药疗法PD-1抑制剂获FDA批准，治疗晚期NSCLC]]></content:encoded><pubDate>Fri, 26 Feb 2021 11:19:38 +0800</pubDate></item><item><title>关注杜丨心衰患者福音！FDA批准诺华Entresto扩大适用范围</title><link>https://mp.weixin.qq.com/s/fXZlRHRdXc-G5N8P0L8Aug</link><description></description><content:encoded><![CDATA[关注杜丨心衰患者福音！FDA批准诺华Entresto扩大适用范围]]></content:encoded><pubDate>Tue, 23 Feb 2021 09:47:37 +0800</pubDate></item><item><title>关注杜丨治疗狼疮性肾炎的第一个口服药物LUPKYNIS™获FDA批准</title><link>https://mp.weixin.qq.com/s/VSeehwyOW3J347DWsPtClg</link><description></description><content:encoded><![CDATA[关注杜丨治疗狼疮性肾炎的第一个口服药物LUPKYNIS™获FDA批准]]></content:encoded><pubDate>Tue, 26 Jan 2021 10:57:51 +0800</pubDate></item><item><title>分享图片</title><link>https://mp.weixin.qq.com/s/U9uqwfMTExlG-LpHhG1ATw</link><description></description><content:encoded><![CDATA[分享图片]]></content:encoded><pubDate>Thu, 31 Dec 2020 21:30:55 +0800</pubDate></item><item><title>关注杜︱疫苗终于来了！FDA批准的第一个新冠疫苗EUA</title><link>https://mp.weixin.qq.com/s/U12H8lDRNmQQZPQGo0AxeA</link><description></description><content:encoded><![CDATA[关注杜︱疫苗终于来了！FDA批准的第一个新冠疫苗EUA]]></content:encoded><pubDate>Wed, 16 Dec 2020 10:12:40 +0800</pubDate></item><item><title>埃格林医药正式启动中/重度新冠肺炎口服治疗药的临床一期试验</title><link>https://mp.weixin.qq.com/s/_klf0BdZpORJJ1ULWec3PA</link><description></description><content:encoded><![CDATA[埃格林医药正式启动中/重度新冠肺炎口服治疗药的临床一期试验]]></content:encoded><pubDate>Wed, 16 Dec 2020 10:12:40 +0800</pubDate></item></channel></rss>